Description
Disease Indications
Rheumatoid Arthritis
Manufacturer
Eli Lilly Nederland B.V.
Usage
Oral
Medicine approved by
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Therapeutic Goods Administration (TGA)
Olumiant (baricitinib)
Price range: $1,000.00 through $1,600.00
Olumiant (baricitinib) is a medication used for the treatment of rheumatoid arthritis and for the treatment of moderate to severe atopic dermatitis.
On November 19, 2020 the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for Olumiant (baricitinib), in combination with Veklury (remdesivir), to treat COVID-19 patients.
Additional information
| Package Tablets | 28 tablets of 2 mg, 98 tablets of 2 mg, 28 tablets of 4 mg, 98 tablets of 4 mg |
|---|
Related products
-
Takhzyro (lanadelumab)
Price range: $9,000.00 through $40,000.00 Select options This product has multiple variants. The options may be chosen on the product page -
Skilarence (dimethyl fumarate)
Price range: $150.00 through $250.00 Select options This product has multiple variants. The options may be chosen on the product page -
Taltz (ixekizumab)
Price range: $1,500.00 through $3,000.00 Select options This product has multiple variants. The options may be chosen on the product page -
Cibinqo (abrocitinib)
Price range: $500.00 through $1,600.00 Select options This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.